MRI引导立体定向放疗治疗局部晚期胰腺癌
本研究纳入20例局部晚期胰腺癌患者,采用定制腹带减少呼吸运动,基于CT和多参数MRI勾画肿瘤及危及器官,结合电影MRI量化运动并模拟运动积分剂量分布,行SBRT 24 Gy/3次/1周。结果显示靶区覆盖充分、危及器官剂量可接受,未观察到≥3级治疗相关毒性,结论为MRI引导SBRT技术可行且安全。
要点
- 定制腹带可减少呼吸运动,结合电影MRI量化肿瘤运动并模拟运动积分剂量。
- 基于CT和多参数MRI可清晰显示肿瘤及危及器官,运动校正后靶区覆盖充分。
- SBRT 24 Gy/3次/1周未观察到≥3级治疗相关毒性。
核心结论
- MRI引导的胰腺癌SBRT技术可行且安全,未观察到治疗相关≥3级毒性。
研究设计与样本
- 单臂可行性研究,2013年7月至2016年1月纳入20例局部晚期胰腺癌患者。
- 使用定制腹带减少呼吸运动,基于CT和多参数MRI勾画肿瘤及危及器官,电影MRI量化肿瘤运动。
- 治疗计划后将静态剂量分布与电影MRI运动轨迹卷积,模拟肿瘤和危及器官的实际交付剂量。
- SBRT处方剂量最高24 Gy,分3次,1周内完成。
- 试验注册于ClinicalTrials.gov(NCT01898741),注册日期2013年7月9日。
关键影像表现/征象
- 对比增强CT和MRI可清晰显示肿瘤及危及器官。
- 考虑运动后模拟交付剂量,靶区覆盖充分,危及器官剂量可接受。
临床应用与阅片要点
- 作者采用定制腹带减少呼吸运动、基于MRI勾画靶区并模拟运动积分剂量分布等新策略。
- 作者认为该流程为局部晚期胰腺癌SBRT提供了MRI整合工作流程,并证明使用腹带减少肿瘤运动的SBRT可行且安全。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE:: We want to explore the safety and technical feasibility of MRI-guided stereotactic radiotherapy for locally advanced pancreatic cancer.
METHODS:: A custom-made abdominal corset was manufactured to reduce breathing induced tumour motion. Delineation of the tumour and organs at risk (OARs) was performed on CT and multiparametric MRI. Tumour motion was quantified with cine MRI. After treatment planning, the static dose distribution was convolved with the cine MRI-based motion trajectory to simulate the delivered dose to the tumour and OARs. Stereotactic body radiation therapy (SBRT) was carried out up to a dose of 24 G in three fractions in 1 week.
RESULTS:: From July 2013 to January 2016, 20 patients were included. Tumours and OARs were clearly visible with contrast-enhanced CT and MRI. After simulation of the delivered dose taking the motion into account, an adequate target coverage was achieved with acceptable dose in the OARs. No Grade3 or higher treatment related toxicity was observed.
CONCLUSION:: MRI-guided SBRT for pancreatic cancer is technical feasible and safe, with no treatment related grade ≥3 toxicity. New strategies are applied, including an individual corset to reduce breathing motion, MRI-based delineation and simulation of motion-integrated dose distributions.
ADVANCES IN KNOWLEDGE:: This article is the first to describe an MRI-integrated workflow in SBRT for locally advanced pancreatic cancer. In addition, it demonstrated that SBRT with an abdominal corset to reduce tumour motion is feasible and safe.
TRIAL REGISTRATION:: This trial was registered at www.clinicaltrials.gov (NCT01898741) on July 9, 2013.
引用
- Heerkens HD, van Vulpen M, Erickson B, et al. MRI guided stereotactic radiotherapy for locally advanced pancreatic cancer. Br J Radiol. 2018. PMID: 30063383. doi:10.1259/bjr.20170563
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。